Bayer | BAYN - Assets


Bayer reported EUR107.94B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Air Liquide EUR 56.28B 4.36B Jun/2026
Akzo Nobel EUR 16.13B 647M Jun/2026
Alcon AG USD 31.62B 64M Mar/2026
Amarin USD 624.36M 21.4M Jun/2026
Arkema EUR 14.17B 48.4M Jun/2026
AstraZeneca USD 115.83B 1.82B Jun/2026
BASF EUR 83.87B 2.1B Jun/2026
Bayer EUR 107.94B 3.4B Mar/2026
Beiersdorf EUR 12.76B 166M Dec/2025
Corteva USD 41.64B 1.08B Jun/2026
Covestro EUR 13.47B 245M Dec/2025
Essilor EUR 65.06B 1.16B Jun/2026
Fresenius EUR 41.84B 526M Jun/2026
Fresenius Medical Care EUR 31.47B 465.26M Mar/2026
Genmab DKK 12.87B 5.85B Dec/2025
Givaudan CHF 11.86B 587M Dec/2025
GlaxoSmithKline GBP 61.74B 1.13B Jun/2026
GRIFOLS EUR 20.09B 12M Jun/2026
Henkel EUR 36.5B 3.96B Jun/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Johnson Matthey GBP 5.97B 142M Jun/2026
Linde USD 86.32B 502M Mar/2026
Lonza CHF 18.97B 164M Dec/2025
Merck EUR 53.07B 1.54B Mar/2026
Novartis USD 122.03B 3.5B Jun/2026
Nutrien USD 53.56B 368M Jun/2026
Philips EUR 26.7B 565M Jun/2026
PPG Industries USD 22.53B 384M Jun/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Sanofi EUR 129.06B 1.04B Jun/2026
SAP EUR 75.61B 2.15B Jun/2026
Solvay EUR 6.08B 122M Jun/2026
UCB EUR 18.16B 971M Dec/2025
Umicore EUR 10.06B 603.5M Jun/2026
Vinci EUR 134.87B 1.8B Jun/2026